IN RE: NAVIDEA BIOPHARMACEUTICALS LITIGATION

Opinion

UNITED STATES DISTRICT COURT DDOACTE # :F ILED: 6/17/24 SOUTHERN DISTRICT OF NEW YORK -------------------------------------------------------------- X : 19-CV-1578 (VEC) IN RE: NAVIDEA BIOPHARMACEUTICALS : LITIGATION : ORDER : -------------------------------------------------------------- X VALERIE CAPRONI, United States District Judge: WHEREAS on June 11, 2024, Mintz & Gold (“M&G”), Navidea’s counsel, filed a motion to withdraw as counsel, see Dkt. 352; WHEREAS the parties appeared before the Court on June 17, 2024; and WHEREAS Navidea represented that it does not object to M&G being relieved and indicated it intends to hire counsel to represent it in this case. IT IS HEREBY ORDERED that because a corporation may not appear in federal court pro se, Kaplan v. Bank Saderat PLC, 77 F.4th 110, 116 n.8 (2d Cir. 2023), Navidea must retain new counsel and that new counsel must file a notice of appearance before close of business on July 17, 2024. IT IS FURTHER ORDERED the parties must appear before the Court for a status conference on July 19, 2024 at 10:00 A.M. in Courtroom 443 of the Thurgood Marshall Courthouse, 40 Foley Square, New York, New York, 10007. IT IS FURTHER ORDERED that M&G must serve this order on Navidea by June 18, 2024 and file proof of service on the docket by June 19, 2024. IT IS FURTHER ORDERED THAT M&G’s motion to withdraw as Navidea’s counsel is GRANTED effective June 19, 2024, contingent on compliance with the requirement to serve a copy of this order on Navidea. IT IS FURTHER ORDERED that Goldberg’s counsel must file a letter requesting that Mr. Weisbrot be terminated as counsel given his passing.

SO ORDERED. \o (oe Date: June 17, 2024 VALERIE CAPRONI New York, New York United States District Judge